Vanguard Group Inc. grew its stake in SelectQuote, Inc. (NYSE:SLQT - Free Report) by 7.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,880,173 shares of the company's stock after purchasing an additional 516,752 shares during the quarter. Vanguard Group Inc. owned about 4.58% of SelectQuote worth $26,320,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of SLQT. Xponance Inc. purchased a new position in shares of SelectQuote during the first quarter valued at about $34,000. Johnson Investment Counsel Inc. purchased a new position in shares of SelectQuote during the 1st quarter worth approximately $35,000. Kapitalo Investimentos Ltda bought a new position in shares of SelectQuote in the 1st quarter worth approximately $35,000. New York State Teachers Retirement System purchased a new position in shares of SelectQuote in the 1st quarter valued at approximately $41,000. Finally, Bayesian Capital Management LP purchased a new position in shares of SelectQuote in the 4th quarter valued at approximately $55,000. 34.59% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on SLQT shares. Jefferies Financial Group assumed coverage on SelectQuote in a research note on Wednesday, May 21st. They issued a "hold" rating and a $2.75 price target on the stock. Wall Street Zen cut shares of SelectQuote from a "buy" rating to a "hold" rating in a report on Sunday, June 22nd. Zacks Research lowered shares of SelectQuote from a "hold" rating to a "strong sell" rating in a research note on Wednesday, August 27th. Finally, Royal Bank Of Canada lowered their price target on shares of SelectQuote from $7.00 to $6.00 and set a "sector perform" rating for the company in a research report on Tuesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $4.42.
View Our Latest Stock Report on SLQT
SelectQuote Stock Performance
Shares of SelectQuote stock traded down $0.11 during trading on Tuesday, hitting $2.16. 525,165 shares of the company's stock traded hands, compared to its average volume of 1,687,594. SelectQuote, Inc. has a 1 year low of $1.62 and a 1 year high of $6.86. The business has a 50-day simple moving average of $2.17 and a 200-day simple moving average of $2.81. The stock has a market capitalization of $372.43 million, a P/E ratio of 43.10 and a beta of 1.27. The company has a debt-to-equity ratio of 0.90, a current ratio of 5.68 and a quick ratio of 5.68.
SelectQuote (NYSE:SLQT - Get Free Report) last announced its quarterly earnings results on Thursday, August 21st. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.18) by $0.01. SelectQuote had a net margin of 3.12% and a return on equity of 6.35%. The firm had revenue of $345.10 million for the quarter, compared to the consensus estimate of $334.09 million. SelectQuote has set its FY 2026 guidance at EPS. As a group, analysts forecast that SelectQuote, Inc. will post -0.07 EPS for the current year.
About SelectQuote
(
Free Report)
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
See Also

Before you consider SelectQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.
While SelectQuote currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.